Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Soy Isoflavone Extract Does Not Increase the Intoxicating Effects of Acute Alcohol Ingestion in Human Volunteers.

Martínez-Riera R, Pérez-Mañá C, Papaseit E, Fonseca F, de la Torre R, Pizarro N, Torrens M, Farré M.

Front Pharmacol. 2019 Feb 27;10:131. doi: 10.3389/fphar.2019.00131. eCollection 2019.

2.

Impact of cell-free fetal DNA on invasive prenatal diagnostic tests in a real-world public setting.

Herraiz I, Villalba A, Ajuria E, Barasoain A, Mendoza A, Pizarro N, Escribano D, Galindo A.

J Perinat Med. 2019 Jul 26;47(5):547-552. doi: 10.1515/jpm-2018-0410.

PMID:
30849049
3.

Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome.

Navarro-Romero A, Vázquez-Oliver A, Gomis-González M, Garzón-Montesinos C, Falcón-Moya R, Pastor A, Martín-García E, Pizarro N, Busquets-Garcia A, Revest JM, Piazza PV, Bosch F, Dierssen M, de la Torre R, Rodríguez-Moreno A, Maldonado R, Ozaita A.

Neurobiol Dis. 2019 May;125:92-106. doi: 10.1016/j.nbd.2019.01.014. Epub 2019 Jan 25.

PMID:
30685352
4.

Improving liquid chromatography-tandem mass spectrometry determination of polycarboxylic acids in human urine by chemical derivatization. Comparison of o-benzyl hydroxylamine and 2-picolyl amine.

Gomez-Gomez A, Soldevila A, Pizarro N, Andreu-Fernandez V, Pozo OJ.

J Pharm Biomed Anal. 2019 Feb 5;164:382-394. doi: 10.1016/j.jpba.2018.10.055. Epub 2018 Nov 3.

PMID:
30466023
5.

The effect of tea consumption on the steroid profile.

Coll S, Matabosch X, Garrostas L, Monfort N, Perez-Maña C, Pizarro N, Mateus JA, Ezzel M, de la Torre R, Ventura R.

Drug Test Anal. 2018 Sep;10(9):1438-1447. doi: 10.1002/dta.2392. Epub 2018 May 3.

PMID:
29659189
6.

The Effect of Pyrazolyl Substituents on the Photophysical and Photochemical Properties of Pyrazine Derivatives.

Pizarro N, Prado G, Saldías M, Sandoval-Altamirano C, Vega A.

Photochem Photobiol. 2018 Sep;94(5):845-852. doi: 10.1111/php.12911. Epub 2018 May 16.

PMID:
29446838
7.

Peripheral endocannabinoid concentrations are not associated with verbal memory impairment during MDMA intoxication.

Haijen E, Farre M, de la Torre R, Pastor A, Olesti E, Pizarro N, Ramaekers JG, Kuypers KPC.

Psychopharmacology (Berl). 2018 Mar;235(3):709-717. doi: 10.1007/s00213-017-4787-2. Epub 2017 Nov 16.

8.

Erratum to: MDMA-induced indifference to negative sounds is mediated by the 5-HT2A receptor.

Kuypers KPC, de la Torre R, Farre M, Pizarro N, Xicota L, Ramaekers JG.

Psychopharmacology (Berl). 2018 Feb;235(2):605. doi: 10.1007/s00213-017-4708-4. No abstract available.

PMID:
28766260
9.

MDMA-Induced Dissociative State not Mediated by the 5-HT2A Receptor.

Puxty DJ, Ramaekers JG, de la Torre R, Farré M, Pizarro N, Pujadas M, Kuypers KPC.

Front Pharmacol. 2017 Jul 11;8:455. doi: 10.3389/fphar.2017.00455. eCollection 2017.

10.

MDMA-induced indifference to negative sounds is mediated by the 5-HT2A receptor.

Kuypers KPC, de la Torre R, Farre M, Pizarro N, Xicota L, Ramaekers JG.

Psychopharmacology (Berl). 2018 Feb;235(2):481-490. doi: 10.1007/s00213-017-4699-1. Epub 2017 Jul 22. Erratum in: Psychopharmacology (Berl). 2017 Aug 1;:.

11.

The first ReI organometallic complex with an organoimido-polyoxometalate ligand.

Hermosilla-Ibáñez P, Wrighton-Araneda K, Prado G, Paredes-García V, Pizarro N, Vega A, Venegas-Yazigi D.

Dalton Trans. 2017 Jul 4;46(26):8611-8620. doi: 10.1039/c7dt01633f.

PMID:
28644503
12.

Fluorescence properties of aurone derivatives: an experimental and theoretical study with some preliminary biological applications.

Espinosa-Bustos C, Cortés-Arriagada D, Soto-Arriaza MA, Robinson-Duggon J, Pizarro N, Cabrera AR, Fuentealba D, Salas CO.

Photochem Photobiol Sci. 2017 Aug 9;16(8):1268-1276. doi: 10.1039/c7pp00078b.

PMID:
28636041
13.

The binuclear dual emitter [Br(CO)3Re(PN)(NP)Re(CO)3Br] (PN): 3-chloro-6-(4-diphenylphosphinyl)butoxypyridazine, a new bridging P,N-bidentate ligand resulting from the ring opening of tetrahydrofuran.

Saldías M, Manzur J, Palacios RE, Gómez ML, Fuente J, Günther G, Pizarro N, Vega A.

Dalton Trans. 2017 Jan 31;46(5):1567-1576. doi: 10.1039/c6dt04158b.

PMID:
28091640
14.

Effect of virgin olive oil and thyme phenolic compounds on blood lipid profile: implications of human gut microbiota.

Martín-Peláez S, Mosele JI, Pizarro N, Farràs M, de la Torre R, Subirana I, Pérez-Cano FJ, Castañer O, Solà R, Fernandez-Castillejo S, Heredia S, Farré M, Motilva MJ, Fitó M.

Eur J Nutr. 2017 Feb;56(1):119-131. doi: 10.1007/s00394-015-1063-2. Epub 2015 Nov 5.

PMID:
26541328
15.

Pharmacokinetic Comparison of Soy Isoflavone Extracts in Human Plasma.

Rodríguez-Morató J, Farré M, Pérez-Mañá C, Papaseit E, Martínez-Riera R, de la Torre R, Pizarro N.

J Agric Food Chem. 2015 Aug 12;63(31):6946-53. doi: 10.1021/acs.jafc.5b02891. Epub 2015 Aug 3.

PMID:
26186408
16.

Flavonoids in Microheterogeneous Media, Relationship between Their Relative Location and Their Reactivity towards Singlet Oxygen.

Günther G, Berríos E, Pizarro N, Valdés K, Montero G, Arriagada F, Morales J.

PLoS One. 2015 Jun 22;10(6):e0129749. doi: 10.1371/journal.pone.0129749. eCollection 2015.

17.

Dual Emission of a Novel (P,N) Re(I) Complex: A Computational and Experimental Study on [P,N-{(C6H5)2(C5H4N)P}Re(CO)3Br].

Pizarro N, Duque M, Chamorro E, Nonell S, Manzur J, de la Fuente JR, Günther G, Cepeda-Plaza M, Vega A.

J Phys Chem A. 2015 Apr 30;119(17):3929-35. doi: 10.1021/jp512614w. Epub 2015 Apr 15.

PMID:
25853537
18.

[Management of difficult airway with inhalation induction in a patient with Lennox-Gastaut syndrome and neck injury].

Rey J, Encabo CM, Pizarro NE, San Martín JL, López-Timoneda F.

Rev Esp Anestesiol Reanim. 2015 Nov;62(9):536-9. doi: 10.1016/j.redar.2015.01.009. Epub 2015 Feb 14. Spanish.

PMID:
25687944
19.

Withdrawal times of oxytetracycline and tylosin in eggs of laying hens after oral administration.

Muñoz R, Cornejo J, Maddaleno A, Araya-Jordán C, Iragüen D, Pizarro N, San Martín B.

J Food Prot. 2014 Jun;77(6):1017-21. doi: 10.4315/0362-028X.JFP-13-440.

PMID:
24853528
20.

Substituent Effect on the Photolability of 4-Aryl-1,4-Dihydropyridines.

García C, Cabezas K, Nonell S, Núñez-Vergara LJ, Morales J, Günther G, Pizarro N.

Photochem Photobiol. 2014 Jan;90(1):73-8. doi: 10.1111/php.12178. Epub 2013 Oct 30.

PMID:
24112052
21.

Dose-dependent metabolic disposition of hydroxytyrosol and formation of mercapturates in rats.

Kotronoulas A, Pizarro N, Serra A, Robledo P, Joglar J, Rubió L, Hernaéz A, Tormos C, Motilva MJ, Fitó M, Covas MI, Solà R, Farré M, Saez G, de la Torre R.

Pharmacol Res. 2013 Nov;77:47-56. doi: 10.1016/j.phrs.2013.09.001. Epub 2013 Sep 14.

PMID:
24044986
22.

3,4-methylenedioxymethamphetamine induces gene expression changes in rats related to serotonergic and dopaminergic systems, but not to neurotoxicity.

Cuyas E, Robledo P, Pizarro N, Farré M, Puerta E, Aguirre N, de la Torre R.

Neurotox Res. 2014 Feb;25(2):161-9. doi: 10.1007/s12640-013-9416-1. Epub 2013 Aug 15.

PMID:
23949956
23.

Solvent and media effects on the photophysics of naphthoxazole derivatives.

Curitol M, Ragas X, Nonell S, Pizarro N, Encinas MV, Rojas P, Zanocco RP, Lemp E, Günther G, Zanocco AL.

Photochem Photobiol. 2013 Nov-Dec;89(6):1327-34. doi: 10.1111/php.12133. Epub 2013 Aug 19.

PMID:
23834078
24.

Long-lasting neuroprotective effect of sildenafil against 3,4-methylenedioxymethamphetamine- induced 5-hydroxytryptamine deficits in the rat brain.

Puerta E, Barros-Miñones L, Hervias I, Gomez-Rodriguez V, Orejana L, Pizarro N, de la Torre R, Jordán J, Aguirre N.

J Neurosci Res. 2012 Feb;90(2):518-28. doi: 10.1002/jnr.22759. Epub 2011 Sep 21.

PMID:
21948520
25.

Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response.

Fonseca F, de la Torre R, Díaz L, Pastor A, Cuyàs E, Pizarro N, Khymenets O, Farré M, Torrens M.

PLoS One. 2011 May 12;6(5):e19527. doi: 10.1371/journal.pone.0019527.

26.

Depletion study of three formulations of flumequine in edible tissues and drug transfer into chicken feathers.

Cornejo J, Lapierre L, Iragüen D, Pizarro N, Hidalgo H, Martín BS.

J Vet Pharmacol Ther. 2011 Apr;34(2):168-75. doi: 10.1111/j.1365-2885.2010.01208.x.

PMID:
21395608
27.

Serotonergic neurotoxic thioether metabolites of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): synthesis, isolation, and characterization of diastereoisomers.

Pizarro N, de la Torre R, Joglar J, Okumura N, Perfetti X, Lau SS, Monks TJ.

Chem Res Toxicol. 2008 Dec;21(12):2272-9. doi: 10.1021/tx8002017.

28.

Neurotoxic thioether adducts of 3,4-methylenedioxymethamphetamine identified in human urine after ecstasy ingestion.

Perfetti X, O'Mathúna B, Pizarro N, Cuyàs E, Khymenets O, Almeida B, Pellegrini M, Pichini S, Lau SS, Monks TJ, Farré M, Pascual JA, Joglar J, de la Torre R.

Drug Metab Dispos. 2009 Jul;37(7):1448-55. doi: 10.1124/dmd.108.026393. Epub 2009 Apr 6.

29.

Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine and its enantiomers in mice: pharmacokinetic considerations.

Fantegrossi WE, Murai N, Mathúna BO, Pizarro N, de la Torre R.

J Pharmacol Exp Ther. 2009 Jun;329(3):1006-15. doi: 10.1124/jpet.109.150573. Epub 2009 Mar 10.

30.

Photophysics and photochemistry of naphthoxazinone derivatives.

Nonell S, Ferreras LR, Cañete A, Lemp E, Günther G, Pizarro N, Zanocco AL.

J Org Chem. 2008 Jul 18;73(14):5371-8. doi: 10.1021/jo800039r. Epub 2008 Jun 14.

PMID:
18553978
31.

MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers.

de la Torre R, Farré M, Mathúna BO, Roset PN, Pizarro N, Segura M, Torrens M, Ortuño J, Pujadas M, Camí J.

Eur J Clin Pharmacol. 2005 Aug;61(7):551-4. Epub 2005 Jul 23. No abstract available.

PMID:
16041599
32.

Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine).

Pizarro N, Farré M, Pujadas M, Peiró AM, Roset PN, Joglar J, de la Torre R.

Drug Metab Dispos. 2004 Sep;32(9):1001-7.

PMID:
15319342
33.

Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition.

de la Torre R, Farré M, Roset PN, Pizarro N, Abanades S, Segura M, Segura J, Camí J.

Ther Drug Monit. 2004 Apr;26(2):137-44. Review.

PMID:
15228154
34.

Solvent effect on the sensitized photooxygenation of 2,3-dihydropyrazine derivatives.

Lemp E, Zanocco AL, Günther G, Pizarro N.

J Org Chem. 2003 Apr 18;68(8):3009-16.

PMID:
12688767
35.

Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites by gas chromatography/mass spectrometry.

Pizarro N, Llebaria A, Cano S, Joglar J, Farré M, Segura J, de la Torre R.

Rapid Commun Mass Spectrom. 2003;17(4):330-6.

PMID:
12569443
36.

High-performance liquid chromatography with electrochemical detection applied to the analysis of 3,4-dihydroxymethamphetamine in human plasma and urine.

Segura M, Ortuño J, McLure JA, Pujadas M, Pizarro N, Farré M, Llebaria A, Joglar J, Segura J, de la Torre R.

J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Apr 5;769(2):313-21.

PMID:
11996497
37.

Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis.

Pizarro N, Ortuño J, Farré M, Hernández-López C, Pujadas M, Llebaria A, Joglar J, Roset PN, Mas M, Segura J, Camí J, de la Torre R.

J Anal Toxicol. 2002 Apr;26(3):157-65.

PMID:
11991532
38.

Synthesis and capillary electrophoretic analysis of enantiomerically enriched reference standards of MDMA and its main metabolites.

Pizarro N, de la Torre R, Farré M, Segura J, Llebaria A, Joglar J.

Bioorg Med Chem. 2002 Apr;10(4):1085-92.

PMID:
11836119
39.

3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics.

Hernández-López C, Farré M, Roset PN, Menoyo E, Pizarro N, Ortuño J, Torrens M, Camí J, de La Torre R.

J Pharmacol Exp Ther. 2002 Jan;300(1):236-44.

PMID:
11752122
40.

3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans.

Segura M, Ortuño J, Farré M, McLure JA, Pujadas M, Pizarro N, Llebaria A, Joglar J, Roset PN, Segura J, de La Torre R.

Chem Res Toxicol. 2001 Sep;14(9):1203-8.

PMID:
11559034
41.

Pharmacology of MDMA in humans.

de la Torre R, Farré M, Roset PN, Lopez CH, Mas M, Ortuño J, Menoyo E, Pizarro N, Segura J, Cami J.

Ann N Y Acad Sci. 2000 Sep;914:225-37.

PMID:
11085324
42.

Quantification of amphetamine plasma concentrations by gas chromatography coupled to mass spectrometry.

Pizarro N, Ortuño J, Segura J, Farré M, Mas M, Camí J, de la Torre R.

J Pharm Biomed Anal. 1999 Dec;21(4):739-47.

PMID:
10701939
43.

Micellar electrokinetic capillary chromatography of macrolide antibiotics. Separation of tylosin, erythromycin and their related substances.

Tobback K, Li YM, Pizarro NA, De Smedt I, Smeets T, Van Schepdael A, Roets E, Hoogmartens J.

J Chromatogr A. 1999 Oct 1;857(1-2):313-20.

PMID:
10536850
44.

Quantification of 3,4-methylenedioxymetamphetamine and its metabolites in plasma and urine by gas chromatography with nitrogen-phosphorus detection.

Ortuño J, Pizarro N, Farré M, Mas M, Segura J, Camí J, Brenneisen R, de la Torre R.

J Chromatogr B Biomed Sci Appl. 1999 Feb 19;723(1-2):221-32.

PMID:
10080649
45.

ACTION OF FSH ON THE NEWLY DIFFERENTIATED TESTIS OF BUFO ARENARUM.

PIZARRO NZ, BURGOS MH.

Gen Comp Endocrinol. 1963 Dec;3:644-8. No abstract available.

PMID:
14088877
46.

[Observations of the development of the gonad of Bufo arenarum].

PISANO A, PIZARRO N.

Rev Soc Argent Biol. 1958 Aug-Sep;34(5-6):175-84. Spanish. No abstract available.

PMID:
13646226

Supplemental Content

Loading ...
Support Center